Marion McCourt's Net Worth
$37.1 Million
Who is Marion McCourt?
Marion McCourt has an estimated net worth of $37.1 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., Axovant Sciences Ltd., SCYNEXIS INC, and MEDIVATION, INC..
SEC CIK
Marion McCourt's CIK is 0001663758
Past Insider Trading and Trends
2022 was Marion McCourt's most active year for acquiring shares with 16 total transactions. Marion McCourt's most active month to acquire stocks was the month of November. 2022 was Marion McCourt's most active year for disposing of shares, totalling 30 transactions. Marion McCourt's most active month to dispose stocks was the month of November. 2024 saw Marion McCourt paying a total of $1,228,746.50 for 3,275 shares, this is the most they've acquired in one year. In 2023 Marion McCourt cashed out on 23,752 shares for a total of $13,118,624.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENERON PHARMACEUTICALS, INC. (REGN) Snapshot price: $1131.5
EVP Commercial
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$613.01 | -$463,210.00 | 12.93K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$780.07 | -$797,330.00 | 12.93K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$709.79 | -$767,077.05 | 12.93K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$676.31 | -$691,562.60 | 12.93K |
Scheduled
|
Jun 3
| ||
Form 4
| -1.90% | -250.00 |
$889.41 | -$222,352.50 | 12.93K |
Scheduled
|
May 1
| ||
Form 4
| -1.86% | -250.00 |
$964.73 | -$241,182.50 | 13.18K |
Scheduled
|
Apr 1
| ||
Form 4
| -2.60% | -358.00 |
$967.50 | -$346,365.00 | 13.43K |
Scheduled
|
Mar 1
| ||
Form 4
| -6.76% | -1.00K |
$934.71 | -$934,710.00 | 13.79K |
Feb 5
| |||
Form 4
| -1.81% | -273.00 |
$945.61 | -$258,151.53 | 14.79K |
Scheduled
|
Feb 1
| ||
Form 4
| -1.79% | -274.00 |
$873.91 | -$239,451.34 | 15.06K |
Scheduled
|
Jan 2
| ||
Form 4
| -24.97% | -5.11K |
$856.71 | -$4,373,504.55 | 15.34K |
Dec 12
| |||
Form 4
| +3.22% | 638 |
$842.90 | -$1,260,133.45 | 20.44K |
Scheduled
|
Dec 8 - Dec 11
| ||
Form 4
|
—
|
0
|
$582.66 | -$402,510.00 | 19.8K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$599.73 | -$471,812.52 | 19.8K |
Oct 2
| |||
Form 4
| -1.25% | -250.00 |
$834.55 | -$208,637.50 | 19.8K |
Sep 1
| |||
Form 4
| -1.23% | -250.00 |
$744.66 | -$186,165.00 | 20.05K |
Aug 1
| |||
Form 4
| -1.22% | -250.00 |
$710.09 | -$177,522.50 | 20.3K |
Jul 3
| |||
Form 4
| -1.20% | -250.00 |
$736.00 | -$184,000.00 | 20.55K |
Jun 1
| |||
Form 4
|
—
|
0
|
$595.63 | -$490,974.00 | 20.8K |
Apr 3
| |||
Form 4
|
—
|
0
|
$566.17 | -$426,173.00 | 20.8K |
Scheduled
|
Mar 1
| ||
Form 4
| -5.78% | -1.28K |
$751.78 | -$959,271.28 | 20.8K |
Feb 12
| |||
Form 4
|
—
|
0
|
$570.75 | -$396,580.00 | 22.08K |
Feb 7
| |||
Form 4
|
—
|
0
|
$562.33 | -$417,703.00 | 22.08K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$547.16 | -$384,340.00 | 22.08K |
Scheduled
|
Jan 3
| ||
Form 4
| +15.56% | 2.97K |
—
|
—
| 22.08K |
Dec 16
| |||
Form 4
| -2.74% | -538.00 |
$741.94 | -$399,163.60 | 19.11K |
Scheduled
|
Dec 9 - Dec 12
| ||
Form 4
|
—
|
0
|
$564.33 | -$422,103.00 | 19.64K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$550.14 | -$355,360.00 | 19.64K |
Nov 4
| |||
Form 4
|
—
|
0
|
$561.23 | -$415,294.00 | 19.64K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$532.22 | -$380,988.00 | 19.64K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$460.28 | -$258,159.00 | 19.64K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$462.23 | -$262,460.00 | 19.64K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$465.35 | -$269,313.00 | 19.64K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$506.22 | -$359,238.00 | 19.64K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$499.95 | -$345,444.00 | 19.64K |
Scheduled
|
May 2
| ||
Form 4
|
—
|
0
|
$522.38 | -$358,890.00 | 19.64K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$479.16 | -$272,460.00 | 19.64K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$475.20 | -$264,530.00 | 19.64K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$483.97 | -$282,070.00 | 19.64K |
Scheduled
|
Jan 3
| ||
Form 4
| -3.59% | -732.00 |
$659.07 | -$482,437.20 | 19.64K |
Scheduled
|
Dec 11 - Dec 13
| ||
Form 4
| +19.59% | 3.34K |
—
|
—
| 20.38K |
Dec 8
| |||
Form 4
|
—
|
0
|
$491.03 | -$296,200.00 | 17.04K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$491.47 | -$297,070.00 | 17.04K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$459.84 | -$233,820.00 | 17.04K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$508.83 | -$331,790.00 | 17.04K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$460.03 | -$234,190.00 | 17.04K |
Scheduled
|
Aug 2
| ||
Form 4
|
—
|
0
|
$449.77 | -$213,670.00 | 17.04K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$427.29 | -$168,720.00 | 17.04K |
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
$419.28 | -$152,700.00 | 17.04K |
May 7
| |||
Form 4
| +22.02% | 3.08K |
—
|
—
| 17.04K |
Dec 9
| |||
Form 4
|
—
|
0
|
$474.51 | -$526,290.00 | 13.96K |
Scheduled
|
Aug 20 - Oct 5
| ||
Form 4
| +11.70% | 1.46K |
—
|
—
| 13.96K |
Dec 11
| |||
Form 4
| +400.00% | 10K |
—
|
—
| 12.5K |
Dec 12
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Principal Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCYNEXIS INC (SCYX) Snapshot price: $1.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIVATION, INC. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -40.99K |
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
∞
| 40.45K |
—
|
—
| 40.45K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||